# Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients

> **NCT02147600** · — · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 82 (actual)

## Conditions studied

- Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02147600
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-09
- **Primary completion:** 2014-04-10
- **Final completion:** 2014-04-10
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02147600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02147600, "Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02147600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*